您当前所在的位置:首页 > 产品中心 > 产品详细信息
6809-52-5 分子结构
点击图片或这里关闭

6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one

ChemBase编号:154595
分子式:C23H38O
平均质量:330.54722
单一同位素质量:330.29226584
SMILES和InChIs

SMILES:
CC(=CCC/C(=C/CC/C(=C/CC/C(=C/CCC(=O)C)/C)/C)/C)C
Canonical SMILES:
C/C(=C\CC/C(=C/CCC(=O)C)/C)/CC/C=C(/CCC=C(C)C)\C
InChI:
InChI=1S/C23H38O/c1-19(2)11-7-12-20(3)13-8-14-21(4)15-9-16-22(5)17-10-18-23(6)24/h11,13,15,17H,7-10,12,14,16,18H2,1-6H3
InChIKey:
HUCXKZBETONXFO-UHFFFAOYSA-N

引用这个纪录

CBID:154595 http://www.chembase.cn/molecule-154595.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one
(5E,9E,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one
IUPAC传统名
6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one
teprenone
别名
6,10,14,18-Tetramethyl-5,9,13,17-nonadecatetraen-2-one, mixture of (5E,9E,13E) and (5Z,9E,13E) isomers
GGA
Selbex
Teprenone
UNII-S8S8451A4O
Geranylgeranylacetone
6,10,14,18-Tetramethyl-5,9,13,17-nonadecatetraen-2-one
E 0671
E 36U31
Geranylgeranylacetone
all-trans-Teprenone
Teprenone
CAS号
6809-52-5
MDL号
MFCD00869547
PubChem SID
162248733
PubChem CID
5282199

数据来源

数据来源

所有数据来源 商品来源 非商品来源
数据来源 数据ID
PubChem 5282199 external link

理论计算性质

理论计算性质

JChem
Acid pKa 19.598763  质子受体
质子供体 LogD (pH = 5.5) 7.001104 
LogD (pH = 7.4) 7.001104  Log P 7.001104 
摩尔折射率 111.4311 cm3 极化性 42.309162 Å3
极化表面积 17.07 Å2 可自由旋转的化学键 12 
里宾斯基五规则 false 

分子性质

分子性质

理化性质 安全信息 产品相关信息 生物活性(PubChem)
溶解度
DMSO: >5 mg/mL expand 查看数据来源
外观
clear liquid expand 查看数据来源
保存条件
protect from light expand 查看数据来源
RTECS编号
RA5391300 expand 查看数据来源
MSDS下载
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
德国WGK号
3 expand 查看数据来源
保存温度
-20°C expand 查看数据来源
纯度
≥98% (HPLC) expand 查看数据来源
质检报告
下载链接 expand 查看数据来源
Empirical Formula (Hill Notation)
C23H38O expand 查看数据来源

详细说明

详细说明

Sigma Aldrich Sigma Aldrich TRC TRC
Sigma Aldrich -  G5048 external link
Biochem/physiol Actions
Geranylgeranylacetone can induce expression of HSP70, HSPB8, and HSPB1. Induction of HSP70 expression is protective against the development of various diseases, such as inflammatory bowel disease, hypoxic/ischemic brain injury and spinal and bulbar muscular atrophy (cytoprotective and anti-inflammatory effects). Reports indicate that GGA protects against NSAID-induced gastric and intestinal lesions by induction of HSP70 expression. Other studies have shown that GGA induces expression of HSPB8 and HSPB1 and reduces the formation of amyloid oligomers as well as insoluble aggregates in HSPB5 R120G TG mice.
Toronto Research Chemicals -  T103500 external link
An anti-ulcerative. Geranylgeranylacetone can induce expression of HSP70, HSPB8, and HSPB1. Induction of HSP70 expression is protective against the development of various diseases, such as inflammatory bowel disease, hypoxic/ischemic brain injury and spin

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • Murakami, M., et al.: Arzneim.-Forsch., 31, 799 (1981)
  • Nishizawa, Y., et al.: Xenobiotica, 17, 575 (1981)
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle